9 Citations (Scopus)

Abstract

The incidence of non-Hodgkin's lymphomas continues to rise and the number of deaths attributable to these malignancies currently rank in the top five causes of cancer-related deaths in the United States. Recent insights into the pathogenesis and molecular characterization of these disorders have led to improvements in a clinicopathologically relevant classification system, as well as in the ability to accurately diagnose specific entities. Several new treatment modalities have been developed which may improve the outcome for selected patients. A better understanding of the biology of non- Hodgkin's lymphomas will hopefully translate into different therapies with improved outcomes. This article describes a new system for classifying the non-Hodgkin's lymphomas, highlights key aspects of the pathogenesis of non- Hodgkin's lymphomas and briefly reviews clinical and therapeutic approaches to the most common of these lymphomas.

Original languageEnglish (US)
Pages (from-to)197-208
Number of pages12
JournalInternal Medicine
Volume39
Issue number3
DOIs
StatePublished - Mar 2000

Fingerprint

Non-Hodgkin's Lymphoma
Lymphoma
Neoplasms
Therapeutics
Incidence

Keywords

  • Classification
  • Pathogenesis
  • Review
  • Treatment

ASJC Scopus subject areas

  • Internal Medicine

Cite this

A new approach to non-Hodgkin's lymphoma. / Hauke, Ralph J.; Armitage, James Olen.

In: Internal Medicine, Vol. 39, No. 3, 03.2000, p. 197-208.

Research output: Contribution to journalReview article

Hauke, Ralph J. ; Armitage, James Olen. / A new approach to non-Hodgkin's lymphoma. In: Internal Medicine. 2000 ; Vol. 39, No. 3. pp. 197-208.
@article{5780a7e46cd345fa9a22811ebcf17f0e,
title = "A new approach to non-Hodgkin's lymphoma",
abstract = "The incidence of non-Hodgkin's lymphomas continues to rise and the number of deaths attributable to these malignancies currently rank in the top five causes of cancer-related deaths in the United States. Recent insights into the pathogenesis and molecular characterization of these disorders have led to improvements in a clinicopathologically relevant classification system, as well as in the ability to accurately diagnose specific entities. Several new treatment modalities have been developed which may improve the outcome for selected patients. A better understanding of the biology of non- Hodgkin's lymphomas will hopefully translate into different therapies with improved outcomes. This article describes a new system for classifying the non-Hodgkin's lymphomas, highlights key aspects of the pathogenesis of non- Hodgkin's lymphomas and briefly reviews clinical and therapeutic approaches to the most common of these lymphomas.",
keywords = "Classification, Pathogenesis, Review, Treatment",
author = "Hauke, {Ralph J.} and Armitage, {James Olen}",
year = "2000",
month = "3",
doi = "10.2169/internalmedicine.39.197",
language = "English (US)",
volume = "39",
pages = "197--208",
journal = "Internal Medicine",
issn = "0918-2918",
publisher = "Japanese Society of Internal Medicine",
number = "3",

}

TY - JOUR

T1 - A new approach to non-Hodgkin's lymphoma

AU - Hauke, Ralph J.

AU - Armitage, James Olen

PY - 2000/3

Y1 - 2000/3

N2 - The incidence of non-Hodgkin's lymphomas continues to rise and the number of deaths attributable to these malignancies currently rank in the top five causes of cancer-related deaths in the United States. Recent insights into the pathogenesis and molecular characterization of these disorders have led to improvements in a clinicopathologically relevant classification system, as well as in the ability to accurately diagnose specific entities. Several new treatment modalities have been developed which may improve the outcome for selected patients. A better understanding of the biology of non- Hodgkin's lymphomas will hopefully translate into different therapies with improved outcomes. This article describes a new system for classifying the non-Hodgkin's lymphomas, highlights key aspects of the pathogenesis of non- Hodgkin's lymphomas and briefly reviews clinical and therapeutic approaches to the most common of these lymphomas.

AB - The incidence of non-Hodgkin's lymphomas continues to rise and the number of deaths attributable to these malignancies currently rank in the top five causes of cancer-related deaths in the United States. Recent insights into the pathogenesis and molecular characterization of these disorders have led to improvements in a clinicopathologically relevant classification system, as well as in the ability to accurately diagnose specific entities. Several new treatment modalities have been developed which may improve the outcome for selected patients. A better understanding of the biology of non- Hodgkin's lymphomas will hopefully translate into different therapies with improved outcomes. This article describes a new system for classifying the non-Hodgkin's lymphomas, highlights key aspects of the pathogenesis of non- Hodgkin's lymphomas and briefly reviews clinical and therapeutic approaches to the most common of these lymphomas.

KW - Classification

KW - Pathogenesis

KW - Review

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0034034337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034034337&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.39.197

DO - 10.2169/internalmedicine.39.197

M3 - Review article

C2 - 10772120

AN - SCOPUS:0034034337

VL - 39

SP - 197

EP - 208

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 3

ER -